SWIFT-MRI imaging and quantitative assessment of IONPs in murine tumors following intra-tumor and systemic delivery

Russell Reeves, Alicia A. Petryk, Elliot J. Kastner, Jinjin Zhang, Hattie L Ring, Michael Garwood, P. Jack Hoopes

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Although preliminary clinical trials are ongoing, successful the use of iron-oxide magnetic nanoparticles (IONP) for heatbased cancer treatments will depend on advancements in: 1) nanoparticle platforms, 2) delivery of a safe and effective alternating magnetic field (AMF) to the tumor, and 3) development of non-invasive, spatially accurate IONP imaging and quantification technique. This imaging technique must be able to assess tumor and normal tissue anatomy as well as IONP levels and biodistribution. Conventional CT imaging is capable of detecting and quantifying IONPs at tissue levels above 10 mg/gram; unfortunately this level is not clinically achievable in most situations. Conventional MRI is capable of imaging IONPs at tissue levels of 0.05 mg/gm or less, however this level is considered to be below the therapeutic threshold. We present here preliminary in vivo data demonstrating the ability of a novel MRI technique, Sweep Imaging with Fourier Transformation (SWIFT), to accurately image and quantify IONPs in tumor tissue in the therapeutic concentration range (0.1-1.0 mg/gm tissue). This ultra-short, T2 MRI method provides a positive Fe contrast enhancement with a reduced signal to noise ratio. Additional IONP signal enhancement techniques such as inversion recovery spectroscopy and variable flip angle (VFA) are also being studied for potential optimization of SWIFT IONP imaging. Our study demonstrates the use of SWIFT to assess IONP levels and biodistribution, in murine flank tumors, following intra-tumoral and systemic IONP administration. ICP-MS and quantitative histological techniques are used to validate the accuracy and sensitivity of SWIFT-based IONP imaging and quantification.

Original languageEnglish (US)
Title of host publicationEnergy-Based Treatment of Tissue and Assessment VIII
EditorsThomas P. Ryan
PublisherSPIE
ISBN (Electronic)9781628414165
DOIs
StatePublished - Jan 1 2015
Event2015 SPIE Conference: Energy-Based Treatment of Tissue and Assessment - San Francisco, United States
Duration: Feb 8 2015Feb 9 2015

Publication series

NameProgress in Biomedical Optics and Imaging - Proceedings of SPIE
Volume9326
ISSN (Print)1605-7422

Conference

Conference2015 SPIE Conference: Energy-Based Treatment of Tissue and Assessment
CountryUnited States
CitySan Francisco
Period2/8/152/9/15

Fingerprint

Fourier transformation
Nanoparticles
Magnetic resonance imaging
iron oxides
Tumors
delivery
Iron oxides
tumors
Imaging techniques
nanoparticles
Neoplasms
Tissue
imaging techniques
Histological Techniques
ferric oxide
inductively coupled plasma mass spectrometry
augmentation
anatomy
Signal-To-Noise Ratio
Oncology

Keywords

  • IONP imaging
  • IONP quantification
  • MRI
  • SWIFT

Cite this

Reeves, R., Petryk, A. A., Kastner, E. J., Zhang, J., Ring, H. L., Garwood, M., & Hoopes, P. J. (2015). SWIFT-MRI imaging and quantitative assessment of IONPs in murine tumors following intra-tumor and systemic delivery. In T. P. Ryan (Ed.), Energy-Based Treatment of Tissue and Assessment VIII [93260Q] (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; Vol. 9326). SPIE. https://doi.org/10.1117/12.2083129

SWIFT-MRI imaging and quantitative assessment of IONPs in murine tumors following intra-tumor and systemic delivery. / Reeves, Russell; Petryk, Alicia A.; Kastner, Elliot J.; Zhang, Jinjin; Ring, Hattie L; Garwood, Michael; Hoopes, P. Jack.

Energy-Based Treatment of Tissue and Assessment VIII. ed. / Thomas P. Ryan. SPIE, 2015. 93260Q (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; Vol. 9326).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Reeves, R, Petryk, AA, Kastner, EJ, Zhang, J, Ring, HL, Garwood, M & Hoopes, PJ 2015, SWIFT-MRI imaging and quantitative assessment of IONPs in murine tumors following intra-tumor and systemic delivery. in TP Ryan (ed.), Energy-Based Treatment of Tissue and Assessment VIII., 93260Q, Progress in Biomedical Optics and Imaging - Proceedings of SPIE, vol. 9326, SPIE, 2015 SPIE Conference: Energy-Based Treatment of Tissue and Assessment, San Francisco, United States, 2/8/15. https://doi.org/10.1117/12.2083129
Reeves R, Petryk AA, Kastner EJ, Zhang J, Ring HL, Garwood M et al. SWIFT-MRI imaging and quantitative assessment of IONPs in murine tumors following intra-tumor and systemic delivery. In Ryan TP, editor, Energy-Based Treatment of Tissue and Assessment VIII. SPIE. 2015. 93260Q. (Progress in Biomedical Optics and Imaging - Proceedings of SPIE). https://doi.org/10.1117/12.2083129
Reeves, Russell ; Petryk, Alicia A. ; Kastner, Elliot J. ; Zhang, Jinjin ; Ring, Hattie L ; Garwood, Michael ; Hoopes, P. Jack. / SWIFT-MRI imaging and quantitative assessment of IONPs in murine tumors following intra-tumor and systemic delivery. Energy-Based Treatment of Tissue and Assessment VIII. editor / Thomas P. Ryan. SPIE, 2015. (Progress in Biomedical Optics and Imaging - Proceedings of SPIE).
@inproceedings{2fd2bbe3bec24beca62918b27f3dc965,
title = "SWIFT-MRI imaging and quantitative assessment of IONPs in murine tumors following intra-tumor and systemic delivery",
abstract = "Although preliminary clinical trials are ongoing, successful the use of iron-oxide magnetic nanoparticles (IONP) for heatbased cancer treatments will depend on advancements in: 1) nanoparticle platforms, 2) delivery of a safe and effective alternating magnetic field (AMF) to the tumor, and 3) development of non-invasive, spatially accurate IONP imaging and quantification technique. This imaging technique must be able to assess tumor and normal tissue anatomy as well as IONP levels and biodistribution. Conventional CT imaging is capable of detecting and quantifying IONPs at tissue levels above 10 mg/gram; unfortunately this level is not clinically achievable in most situations. Conventional MRI is capable of imaging IONPs at tissue levels of 0.05 mg/gm or less, however this level is considered to be below the therapeutic threshold. We present here preliminary in vivo data demonstrating the ability of a novel MRI technique, Sweep Imaging with Fourier Transformation (SWIFT), to accurately image and quantify IONPs in tumor tissue in the therapeutic concentration range (0.1-1.0 mg/gm tissue). This ultra-short, T2 MRI method provides a positive Fe contrast enhancement with a reduced signal to noise ratio. Additional IONP signal enhancement techniques such as inversion recovery spectroscopy and variable flip angle (VFA) are also being studied for potential optimization of SWIFT IONP imaging. Our study demonstrates the use of SWIFT to assess IONP levels and biodistribution, in murine flank tumors, following intra-tumoral and systemic IONP administration. ICP-MS and quantitative histological techniques are used to validate the accuracy and sensitivity of SWIFT-based IONP imaging and quantification.",
keywords = "IONP imaging, IONP quantification, MRI, SWIFT",
author = "Russell Reeves and Petryk, {Alicia A.} and Kastner, {Elliot J.} and Jinjin Zhang and Ring, {Hattie L} and Michael Garwood and Hoopes, {P. Jack}",
year = "2015",
month = "1",
day = "1",
doi = "10.1117/12.2083129",
language = "English (US)",
series = "Progress in Biomedical Optics and Imaging - Proceedings of SPIE",
publisher = "SPIE",
editor = "Ryan, {Thomas P.}",
booktitle = "Energy-Based Treatment of Tissue and Assessment VIII",
address = "United States",

}

TY - GEN

T1 - SWIFT-MRI imaging and quantitative assessment of IONPs in murine tumors following intra-tumor and systemic delivery

AU - Reeves, Russell

AU - Petryk, Alicia A.

AU - Kastner, Elliot J.

AU - Zhang, Jinjin

AU - Ring, Hattie L

AU - Garwood, Michael

AU - Hoopes, P. Jack

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Although preliminary clinical trials are ongoing, successful the use of iron-oxide magnetic nanoparticles (IONP) for heatbased cancer treatments will depend on advancements in: 1) nanoparticle platforms, 2) delivery of a safe and effective alternating magnetic field (AMF) to the tumor, and 3) development of non-invasive, spatially accurate IONP imaging and quantification technique. This imaging technique must be able to assess tumor and normal tissue anatomy as well as IONP levels and biodistribution. Conventional CT imaging is capable of detecting and quantifying IONPs at tissue levels above 10 mg/gram; unfortunately this level is not clinically achievable in most situations. Conventional MRI is capable of imaging IONPs at tissue levels of 0.05 mg/gm or less, however this level is considered to be below the therapeutic threshold. We present here preliminary in vivo data demonstrating the ability of a novel MRI technique, Sweep Imaging with Fourier Transformation (SWIFT), to accurately image and quantify IONPs in tumor tissue in the therapeutic concentration range (0.1-1.0 mg/gm tissue). This ultra-short, T2 MRI method provides a positive Fe contrast enhancement with a reduced signal to noise ratio. Additional IONP signal enhancement techniques such as inversion recovery spectroscopy and variable flip angle (VFA) are also being studied for potential optimization of SWIFT IONP imaging. Our study demonstrates the use of SWIFT to assess IONP levels and biodistribution, in murine flank tumors, following intra-tumoral and systemic IONP administration. ICP-MS and quantitative histological techniques are used to validate the accuracy and sensitivity of SWIFT-based IONP imaging and quantification.

AB - Although preliminary clinical trials are ongoing, successful the use of iron-oxide magnetic nanoparticles (IONP) for heatbased cancer treatments will depend on advancements in: 1) nanoparticle platforms, 2) delivery of a safe and effective alternating magnetic field (AMF) to the tumor, and 3) development of non-invasive, spatially accurate IONP imaging and quantification technique. This imaging technique must be able to assess tumor and normal tissue anatomy as well as IONP levels and biodistribution. Conventional CT imaging is capable of detecting and quantifying IONPs at tissue levels above 10 mg/gram; unfortunately this level is not clinically achievable in most situations. Conventional MRI is capable of imaging IONPs at tissue levels of 0.05 mg/gm or less, however this level is considered to be below the therapeutic threshold. We present here preliminary in vivo data demonstrating the ability of a novel MRI technique, Sweep Imaging with Fourier Transformation (SWIFT), to accurately image and quantify IONPs in tumor tissue in the therapeutic concentration range (0.1-1.0 mg/gm tissue). This ultra-short, T2 MRI method provides a positive Fe contrast enhancement with a reduced signal to noise ratio. Additional IONP signal enhancement techniques such as inversion recovery spectroscopy and variable flip angle (VFA) are also being studied for potential optimization of SWIFT IONP imaging. Our study demonstrates the use of SWIFT to assess IONP levels and biodistribution, in murine flank tumors, following intra-tumoral and systemic IONP administration. ICP-MS and quantitative histological techniques are used to validate the accuracy and sensitivity of SWIFT-based IONP imaging and quantification.

KW - IONP imaging

KW - IONP quantification

KW - MRI

KW - SWIFT

UR - http://www.scopus.com/inward/record.url?scp=84930452957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930452957&partnerID=8YFLogxK

U2 - 10.1117/12.2083129

DO - 10.1117/12.2083129

M3 - Conference contribution

T3 - Progress in Biomedical Optics and Imaging - Proceedings of SPIE

BT - Energy-Based Treatment of Tissue and Assessment VIII

A2 - Ryan, Thomas P.

PB - SPIE

ER -